Home
Conditions
Lymphoma

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

3,646 public trials 848 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma trial results

Not Yet Recruiting

Characterization of the Microbiome in Cutaneous T Cell Lymphoma Skin Lesions Before and After Use of APR-TD011® (RLF-TD011®) Spray Solution

NCT05728879

Conditions: Cutaneous T Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Dermatology CTU Chicago, Illinois, United States

View Trial Details

Not Yet Recruiting

Nanobody-Based CD19/CD20 Tandem Dual CAR-T-cell Therapy of Relapsed/Refractory B-Cell Lymphoma

NCT07546630

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Selinexor Combined With Reduced-Dose Radiotherapy For Early-Stage Extranodal NK/T-Cell Lymphoma

NCT07554482

Conditions: Extranodal NK/T-cell Lymphoma, Lymphoma, Lymphoma, Extranodal NK-T-Cell, +4 more
Locations: Beijing Tongren Hospital, Capital Medical University Beijing, China

View Trial Details

Not Yet Recruiting

Pharmacokinetics and Safety of MDR-001 in Mild and Moderate Hepatic Impairment

NCT07550634

Conditions: Digestive System Diseases, Hemic and Lymphatic Diseases, Hepatic Impairment (Mild and Moderate, Child-Pugh Class A and B), +12 more
Locations: The First Hospital of Jilin University Changchun, Jilin, China

View Trial Details

Not Yet Recruiting

Sonrotoclax, Zanubrutinib and Rituximab in Previously Untreated Patients With Follicular Lymphoma

NCT07550855

Conditions: Follicular Lymphoma (FL), Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Sun Yat-sen Universitiy Cancer Center Guangzhou, Guangdong, China

View Trial Details

Not Yet Recruiting

Sintilimab, Chidamide, and Azacitidine for Untreated Stage I-II Extranodal NK/T-Cell Lymphoma

NCT07542912

Conditions: Adverse Event, Complete Remission Rate， CRR, Duration of Response, +8 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, China

View Trial Details

Not Yet Recruiting

Phase I Clinical Study on the Safety and Efficacy of CY-219 CAR-T Cell Injection in the Treatment of Relapsed/Refractory B-Cell Lymphoma

NCT07539688

Conditions: Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Epidemiology and Management of Cutaneous T-Cell Lymphoma at Hospital México, Costa Rica.

NCT07538960

Conditions: Cutaneous, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: Hospital México San José, Uruca, Costa Rica

View Trial Details

Not Yet Recruiting

Aclarubicin Plus Cyclophosphamide, Vincristine, and Prednisone (CAOP) in Patients With Previously Treated Cutaneous T-cell Lymphoma

NCT07535710

Conditions: Cutaneous T Cell Lymphoma (CTCL), Cutaneous T-Cell Lymphoma Refractory, Cutaneous T-Cell Lymphoma, Relapsed, +16 more
Locations: Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Shanghai, China

Ruijin Hospital Wuxi Branch Wuxi, China

View Trial Details

Not Yet Recruiting

Aclarubicin Plus Cyclophosphamide, Vincristine, and Prednisone (CAOP) in Patients With Previously Untreated Peripheral T-Cell Lymphoma

NCT07535762

Conditions: Anaplastic Large Cell Lymphoma (ALCL) (ALK-1 Negative), Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations: Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Shanghai, China

Ruijin Hospital Wuxi Branch Wuxi, China

View Trial Details

Lymphoma

Lymphoma trial results

Related conditions